Cargando…

Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical

The first annual Stroke Translational Research Advancement Workshop (STRAW), entitled “Uncovering the Rosetta Stone: Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical” was held at the University of Kentucky on October 4–5, 2017. This workshop was organized by the Center f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bix, Gregory J., Fraser, Justin F., Mack, William J., Carmichael, S. Thomas, Perez-Pinzon, Miguel, Offner, Halina, Sansing, Lauren, Bosetti, Francesca, Ayata, Cenk, Pennypacker, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982459/
https://www.ncbi.nlm.nih.gov/pubmed/29633156
http://dx.doi.org/10.1007/s12975-018-0628-9
_version_ 1783328246745530368
author Bix, Gregory J.
Fraser, Justin F.
Mack, William J.
Carmichael, S. Thomas
Perez-Pinzon, Miguel
Offner, Halina
Sansing, Lauren
Bosetti, Francesca
Ayata, Cenk
Pennypacker, Keith R.
author_facet Bix, Gregory J.
Fraser, Justin F.
Mack, William J.
Carmichael, S. Thomas
Perez-Pinzon, Miguel
Offner, Halina
Sansing, Lauren
Bosetti, Francesca
Ayata, Cenk
Pennypacker, Keith R.
author_sort Bix, Gregory J.
collection PubMed
description The first annual Stroke Translational Research Advancement Workshop (STRAW), entitled “Uncovering the Rosetta Stone: Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical” was held at the University of Kentucky on October 4–5, 2017. This workshop was organized by the Center for Advanced Translational Stroke Science. The workshop consisted of 2 days of activities. These included three presentations establishing the areas of research in stroke therapeutics, discussing the routes for translation from bench to bedside, and identifying successes and failures in the field. On day 2, grant funding opportunities and goals for the National Institute for Neurological Diseases and Stroke were presented. In addition, the meeting also included break-out sessions designed to connect researchers in areas of stroke, and to foster potential collaborations. Finally, the meeting concluded with an open discussion among attendees led by a panel of experts.
format Online
Article
Text
id pubmed-5982459
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-59824592018-06-11 Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical Bix, Gregory J. Fraser, Justin F. Mack, William J. Carmichael, S. Thomas Perez-Pinzon, Miguel Offner, Halina Sansing, Lauren Bosetti, Francesca Ayata, Cenk Pennypacker, Keith R. Transl Stroke Res Commentary The first annual Stroke Translational Research Advancement Workshop (STRAW), entitled “Uncovering the Rosetta Stone: Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical” was held at the University of Kentucky on October 4–5, 2017. This workshop was organized by the Center for Advanced Translational Stroke Science. The workshop consisted of 2 days of activities. These included three presentations establishing the areas of research in stroke therapeutics, discussing the routes for translation from bench to bedside, and identifying successes and failures in the field. On day 2, grant funding opportunities and goals for the National Institute for Neurological Diseases and Stroke were presented. In addition, the meeting also included break-out sessions designed to connect researchers in areas of stroke, and to foster potential collaborations. Finally, the meeting concluded with an open discussion among attendees led by a panel of experts. Springer US 2018-04-10 2018 /pmc/articles/PMC5982459/ /pubmed/29633156 http://dx.doi.org/10.1007/s12975-018-0628-9 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Commentary
Bix, Gregory J.
Fraser, Justin F.
Mack, William J.
Carmichael, S. Thomas
Perez-Pinzon, Miguel
Offner, Halina
Sansing, Lauren
Bosetti, Francesca
Ayata, Cenk
Pennypacker, Keith R.
Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
title Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
title_full Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
title_fullStr Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
title_full_unstemmed Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
title_short Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
title_sort uncovering the rosetta stone: report from the first annual conference on key elements in translating stroke therapeutics from pre-clinical to clinical
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982459/
https://www.ncbi.nlm.nih.gov/pubmed/29633156
http://dx.doi.org/10.1007/s12975-018-0628-9
work_keys_str_mv AT bixgregoryj uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT fraserjustinf uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT mackwilliamj uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT carmichaelsthomas uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT perezpinzonmiguel uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT offnerhalina uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT sansinglauren uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT bosettifrancesca uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT ayatacenk uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical
AT pennypackerkeithr uncoveringtherosettastonereportfromthefirstannualconferenceonkeyelementsintranslatingstroketherapeuticsfrompreclinicaltoclinical